Close
Listen

Aims

We aim to translate newly identified (digital, imaging and molecular) biomarkers, novel therapies (small molecules, antisense oligonucleotides and cell therapies) and rehabilitation strategies into clinical care and to evaluate their effect on quality of life.


go to main content
Research Research groups Muscular diseases

About Muscular diseases

We focus on neuromuscular disorders, including Duchenne Muscular Dystrophy, Myotonic Dystrophy, Congenital Myopathies and FSHD, aiming for personalized treatments, patient involvement, and improved quality of life through new therapies.

Research group leader

prof. dr. Nicol Voermans

Aims

See our most important goals.

read more

Publications

See some of our most important scientific articles.

read more
Close
Listen

Publications

See the publication list of the research group leader on Web of Science.


Profile page

See the group leader's profile.

see page

Research programs

Programs that are connected to this research group.

Our members

see full team